Jennerex Biotherapeutics focused on the development and commercialization of targeted oncolytic immunotherapies for solid tumors.
Business Model:
Revenue: $0
Employees: 11-50
Jennerex Biotherapeutics was acquired by
SillaJen.
The acquisition happend on 2013-11-25.
Details of the transaction were not public
Address: 450 Sansome St
City: San Francisco
State: CA
Zip: 94111
Country: US
Jennerex Biotherapeutics focused on the development and commercialization of targeted oncolytic immunotherapies for solid tumors.
Contact Phone:
+14152818886
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2010 | Series D | $8.6M | 8/2011 | Venture Round | $8.6M | 9/2008 | Series B | $8.3M | 5/2013 | Private Equity Round | $21.6M | 10/2011 | Venture Round | $1.8M | 6/2007 | Series A | $1.7M | 9/2009 | Series C | $0 |
Ottawa Regional Cancer Foundation Ottawa Regional Cancer Foundation |
9/2009 | Series C | 1 | $5.5M |
Ottawa Regional Cancer Foundation Ottawa Regional Cancer Foundation |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|